autoimmune diseases
Amgen Successfully Completes $27.8B Acquisition of Horizon After FTC Dispute Resolution
Anika Sharma
Amgen has successfully concluded its monumental $27.8 billion acquisition of Horizon Therapeutics, triumphing over a legal challenge posed by the ...
Aurinia appoints founder and former CEO Robert Foster to board as part of cooperation agreement with MKT Capital
Anika Sharma
Aurinia Pharmaceuticals, known for its focus on autoimmune diseases, has taken steps to address investor concerns by appointing its founder ...
NexImmune slashes staff again as cash crunch looms over its nanoparticle platform
Anika Sharma
NexImmune, the immunotherapy biotech, is once again in the spotlight for layoff as it nears the end of its financial ...
